Getagraph.com logo
S&P 500
(0.32%) 5 116.17 points
Dow Jones
(0.38%) 38 386 points
Nasdaq
(0.35%) 15 983 points
Oil
(-0.02%) $82.61
Gas
(0.79%) $2.05
Gold
(-0.53%) $2 345.10
Silver
(-1.01%) $27.38
Platinum
(-0.14%) $960.20
USD/EUR
(0.09%) $0.933
USD/NOK
(0.10%) $10.99
USD/GBP
(0.02%) $0.796
USD/RUB
(0.01%) $93.31

Sanntidsoppdatering for NeuroMetrix Inc [NURO]

Børs: NASDAQ Sektor: Healthcare Industri: Medical Devices
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 14.14%

Sist oppdatert29 apr 2024 @ 22:00
25% discount on Stockinvest.us - Use code: Podcast

5.86% $ 4.70

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 22:00):

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico...

Stats
Dagens volum 8 197.00
Gjennomsnittsvolum 50 182.00
Markedsverdi 9.34M
EPS $0 ( 2024-02-22 )
Neste inntjeningsdato ( $0 ) 2024-05-01
Last Dividend $1 728.00 ( 2007-03-28 )
Next Dividend $0 ( N/A )
P/E -0.750
ATR14 $0.0440 (0.94%)
Insider Trading
Date Person Action Amount type
2024-04-18 Horowitz Joshua Buy 16 438 Common Stock
2024-04-18 Horowitz Joshua Buy 0 Common Stock
2024-04-18 Horowitz Joshua Sell 0 Common Stock
2024-04-01 Higgins Thomas T Buy 469 Common Stock
2024-04-01 Higgins Thomas T Sell 74 Common Stock
INSIDER POWER
54.21
Last 97 transactions
Buy: 971 558 | Sell: 254 579

NeuroMetrix Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

NeuroMetrix Inc Økonomi

Annual 2023
Omsetning: $5.90M
Bruttogevinst: $3.95M (66.89 %)
EPS: $-6.27
FY 2023
Omsetning: $5.90M
Bruttogevinst: $3.95M (66.89 %)
EPS: $-6.27
FY 2022
Omsetning: $8.26M
Bruttogevinst: $5.75M (69.65 %)
EPS: $-4.90
FY 2021
Omsetning: $8.25M
Bruttogevinst: $5.92M (71.75 %)
EPS: $-0.342

Financial Reports:

No articles found.

NeuroMetrix Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

NeuroMetrix Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $1 728.00 2007-03-28
Last Dividend $1 728.00 2007-03-28
Next Dividend $0 N/A
Payout Date 2007-04-13
Next Payout Date N/A
# dividends 1 --
Total Paid Out $1 728.00 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-04-29)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2007 $1.000 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1.0831.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.2981.200-9.95-10.00[0 - 0.3]
returnOnEquityTTM-0.3071.500-4.52-6.78[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM16.810.80010.008.00[1 - 3]
quickRatioTTM14.920.80010.008.00[0.8 - 2.5]
cashRatioTTM1.3961.5003.365.03[0.2 - 2]
debtRatioTTM0.0112-1.5009.81-10.00[0 - 0.6]
interestCoverageTTM52.631.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
freeCashFlowPerShareTTM-4.112.00-2.06-4.11[0 - 20]
debtEquityRatioTTM0.0120-1.5009.95-10.00[0 - 2.5]
grossProfitMarginTTM0.6691.0002.192.19[0.2 - 0.8]
operatingProfitMarginTTM-1.2121.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-25.261.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.2750.800-1.497-1.198[0.5 - 2]
Total Score-0.253

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.0591.000-0.2080[1 - 100]
returnOnEquityTTM-0.3072.50-2.90-6.78[0.1 - 1.5]
freeCashFlowPerShareTTM-4.112.00-1.370-4.11[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.03611.500-3.570[0.5 - 2]
operatingCashFlowSalesRatioTTM-1.0311.000-10.000[0.1 - 0.5]
Total Score-2.82

NeuroMetrix Inc

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.